Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation


Ösken A., YELGEÇ N. S., ZEHİR R., Öz T. K., Yaylaci S., Akdemir R., ...Daha Fazla

Indian Journal of Pharmacology, cilt.48, sa.4, ss.462-465, 2016 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 4
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4103/0253-7613.186193
  • Dergi Adı: Indian Journal of Pharmacology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.462-465
  • Anahtar Kelimeler: Chlorpheniramine, drug-induced torsades de pointes, propranolol
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Drug-induced torsades de pointes (TdP) is a rare but potentially fatal adverse effect of commonly prescribed medications including cardiac and noncardiac drugs. Importantly, many drugs have been reported to cause the characteristic Brugada syndrome-linked electrocardiography (ECG) abnormalities and/or (fatal) ventricular tachyarrhythmias. Chlorpheniramine and propranolol have the arrhythmogenic effects reported previously. A review of literature revealed a large number of case reports of chlorpheniramine or propranolol use resulting in QTc prolongation, TdP, or both. However, we wish to report the case of a patient who was treated with a combination of chlorpheniramine and propranolol, whose ECG showed no QT prolongation but who suffered from cardiac arrest due to TdP.